Relmada Therapeutics, Inc.Relmada Therapeutics, Inc.Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪134.28 M‬USD
−3.28USD
‪−98.79 M‬USD
‪25.39 M‬
Beta (1Y)
1.41

About Relmada Therapeutics, Inc.

CEO
Sergio Traversa
Headquarters
Coral Gables
Employees (FY)
20
Founded
2012
ISIN
US75955J4022
FIGI
BBG003MKSL16
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications. The company was founded by Paolo Manfredi on May 31, 2012 and is headquartered in Coral Gables, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of RLMD is 4.56 USD — it has increased by 2.47% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Relmada Therapeutics, Inc. stocks are traded under the ticker RLMD.
Relmada Therapeutics, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Relmada Therapeutics, Inc. has a max estimate of 25.00 USD and a min estimate of 3.00 USD.
RLMD earnings for the last quarter are −0.73 USD whereas the estimation was −0.91 USD which accounts for 20.13% surprise. Estimated earnings for the next quarter are −0.83 USD. See more details about Relmada Therapeutics, Inc. earnings.
Yes, you can track Relmada Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, RLMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Relmada Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
RLMD reached its all-time high on Jun 25, 2020 with the price of 54.00 USD, and its all-time low was 1.81 USD and was reached on Dec 8, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 20.00 employees. See our rating of the largest employees — is Relmada Therapeutics, Inc. on this list?